HIV 1 News and Research

RSS

Study: Many gay and bisexual teenage boys use adult hookup apps to connect with friends, partners

Although hookup apps require users to be 18 or older, a new Northwestern Medicine study found that more than 50 percent of sexually active gay and bisexual boys ages 14 to 17 met male sexual partners on apps such as Grindr and Scruff.

18 May 2018

Natural antioxidant bilirubin may provide cardiovascular benefits

Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology study.

18 May 2018

New CRISPR/Cas9 system targets regulatory genes of AIDS virus

By destroying the regulatory genes of the AIDS virus HIV-1 using the genome editing system CRISPR/Cas9, a Japanese research group has succeeded in blocking the production of HIV-1 by infected cells.

18 May 2018

HIV patients on single-tablet regimen show better outcomes than those taking multiple pills

HIV patients on a single-tablet daily regimen had better treatment retention and viral suppression than patients taking multiple pills, in a study by a Michael E. DeBakey Veterans Affairs Medical Center researcher and his colleagues.

18 May 2018

Experts available to discuss subjects related to Ebola virus

Georgetown University Medical Center (GUMC) professors offer expertise for journalists seeking interviews in a variety of subjects related to Ebola.

18 May 2018

Study: Social connections may protect black men who have sex with men from acquiring HIV

UCLA-led research suggests that receiving support from friends and acquaintances can help prevent black men who have sex with men from becoming infected with HIV.

17 May 2018

California’s deadly STD epidemic sets record

Diagnoses of sexually transmitted diseases hit a record high in California last year — with sometimes deadly consequences, according to preliminary state data released this week.

17 May 2018

Study finds distinct exhausted T cells that could have implications for fighting different diseases

The battle between the human immune system and long-term, persisting infections and other chronic diseases such as cancer results in a prolonged stalemate

16 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

Scientists discover a mechanism through which HIV determines the fate and function of cells

A stem cell is one with infinite possibilities. So, for decades, scientists have puzzled over how the cell chooses to keep being a stem cell and continue dividing, or specialize into a specific cell type, like a heart or brain cell.

11 May 2018

New studies use proteomics to shed light on pathogenic mechanisms

Recent studies in the journal Molecular & Cellular Proteomics have shed light on pathogenic mechanisms of the sexually-transmitted parasite Trichomonas vaginalis and the HIV-associated opportunistic lung fungus Aspergillus.

11 May 2018

Study examines social perceptions of HIV-prevention drug among gay and bisexual men

A new study led by a UTSA researcher examines the social perceptions of Pre-Exposure Prophylaxis (PrEP), a medication to prevent HIV, among gay and bisexual men in Texas.

9 May 2018

Research findings could lead to new therapies to curb ovarian cancer metastasis

In order to spread their destruction, ovarian cancer cells must break free from their tumor home, travel through the fluid in the peritoneal cavity and attach to the outside of the abdominal organs--surfaces that are, by necessity, not sticky.

9 May 2018

Stimulant use may negatively affect health of HIV-positive persons

A researcher at the University of Miami Miller School of Medicine has found that the use of stimulants, such as methamphetamine, can negatively affect the health of HIV-positive persons even when they are adhering to medical treatment.

4 May 2018

Unexpected discovery could improve detection of malaria infections

While the global health community has made great strides toward eradicating malaria through prevention and treatment strategies, rapid and inexpensive methods to diagnose submicroscopic malaria in individuals who have no clinical symptoms and undetectable levels of disease-causing parasites in their blood remain an unmet need.

4 May 2018

New survey highlights need for BV awareness and education to ensure proper care

Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).

4 May 2018

Study underlines importance of early HIV treatment to avoid brain atrophy

While the human immunodeficiency virus (HIV) has largely dropped from news headlines since the 1990s, at the end of 2016 there were 36.7 million people living with the infection, and of those only 53 per cent had access to treatment.

3 May 2018

Scripps Research team receives $12 million grant to improve flu and malaria vaccines

Scientists at The Scripps Research Institute aim to improve flu and malaria vaccines with the support of a new $12 million grant from the Bill & Melinda Gates Foundation.

3 May 2018

Study: 40% of people diagnosed with HIV do not disclose their status in rural Mozambique

Almost 40% of people previously diagnosed with HIV do not disclose their HIV status during diagnosis campaigns, leading to unnecessary retesting. In addition to wasting valuable resources, this phenomenon can distort indicators of progress towards the UNAIDS targets.

2 May 2018

Research findings challenge feasibility of 'shock and kill' approach to cure HIV

Researchers have provided new insight into the cellular processes behind the 'shock and kill' approach to curing HIV, which they say challenges the effectiveness of the treatment.

2 May 2018

HIV 1 News and Research

Study: Many gay and bisexual teenage boys use adult hookup apps to connect with friends, partners

Natural antioxidant bilirubin may provide cardiovascular benefits

New CRISPR/Cas9 system targets regulatory genes of AIDS virus

HIV patients on single-tablet regimen show better outcomes than those taking multiple pills

Experts available to discuss subjects related to Ebola virus

Study: Social connections may protect black men who have sex with men from acquiring HIV

California’s deadly STD epidemic sets record

Study finds distinct exhausted T cells that could have implications for fighting different diseases

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

Scientists discover a mechanism through which HIV determines the fate and function of cells

New studies use proteomics to shed light on pathogenic mechanisms

Study examines social perceptions of HIV-prevention drug among gay and bisexual men

Research findings could lead to new therapies to curb ovarian cancer metastasis

Stimulant use may negatively affect health of HIV-positive persons

Unexpected discovery could improve detection of malaria infections

New survey highlights need for BV awareness and education to ensure proper care

Study underlines importance of early HIV treatment to avoid brain atrophy

Scripps Research team receives $12 million grant to improve flu and malaria vaccines

Study: 40% of people diagnosed with HIV do not disclose their status in rural Mozambique

Research findings challenge feasibility of 'shock and kill' approach to cure HIV

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News